Prevalence of Meibomian Gland Dysfunction in Patients with Keratoconus in an Optometry Clinic in the Palestinian Authority
Open Access
- 9 January 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (1) , 134
Abstract
Background/Objectives: Meibomian gland dysfunction (MGD) has been shown to be more prevalent in patients with keratoconus (KC) in Turkey, Egypt, and Israel but has not been examined in the Palestinian Authority (PA). Therefore, this study compared the prevalence and clinical features of MGD in patients with keratoconus versus healthy controls seen in an optometry clinic in the PA. Methods: Patients with KC and healthy controls who were non-contact lens wearers were recruited. Habitual visual acuity (VA), tear break-up time (TBUT), meibography, meibomian gland (MG) expressibility (MES) and quality score (MQS), and Schirmer test were evaluated. MGD was defined by an Ocular Surface Disease Index (OSDI) Questionnaire score ≥ 13, TBUT < 10 s, and MG loss > Grade 1. Outcomes were compared using Mann–Whitney U tests, Chi-Square tests and Spearman correlation. Results: The study included 33 eyes of 17 KC (mean age: 29.2 ± 7.7, range:19–50) and 27 right eyes of 27 control participants (mean age: 34.2 ± 11.7, range:18–56). MGD was prevalent in 67% of KC and 30% of control participants. VA was significantly worse (0.8 + 0.2 vs. 1.0 + 0.0, p < 0.001), with significantly greater MG loss in the lower eyelids (p = 0.002), and shorter TBUT (4.1 ± 1.5 s vs. 5.7 ± 1.7 s, p < 0.001) in the KC group. No significant differences were found in symptoms, MES, MQS, MG loss in the upper eyelids, or Schirmer test. Conclusions: KC patients exhibited a significantly higher prevalence and severity of MGD signs compared with controls. These findings highlight the importance of comprehensive ocular surface evaluation and management in this population.Keywords
This publication has 60 references indexed in Scilit:
- Sun‐Safety Knowledge, Attitudes and Behaviour in Western Saudi Arabia: Implications for Psycho‐Oncology Prevention ServicesPsycho-Oncology, 2025
- TFOS DEWS III: Diagnostic MethodologyAmerican Journal of Ophthalmology, 2025
- Prevalence and Incidence of Dry Eye and Meibomian Gland Dysfunction in the United StatesJAMA Ophthalmology, 2022
- Clinical evaluation of meibomian gland dysfunction in patients with keratoconusContact Lens and Anterior Eye, 2022
- Associations with meibomian gland loss in soft and rigid contact lens wearersContact Lens and Anterior Eye, 2022
- Impact of blinking on ocular surface and tear film parametersThe Ocular Surface, 2018
- Meibomian gland dysfunction and its determinants in Iranian adults: A population-based studyContact Lens and Anterior Eye, 2017
- TFOS DEWS II Diagnostic Methodology reportThe Ocular Surface, 2017
- Precision (repeatability and reproducibility) studies and sample-size calculationJournal of Cataract & Refractive Surgery, 2015
- Reliability and Validity of the Ocular Surface Disease IndexArchives of Ophthalmology (1950), 2000